The results obtained from the evaluation of “GetSMART” showed a remaining need to enhance clinicians’ knowledge in relation to precision-medicine and team-based care affecting patients with G&CRC due to HER2+ status, which suggests that current interventions focusing on knowledge acquisition are appropriate. This evidence concerns the gene ERBB2 and colorectal carcinoma.